Open CFD account Free Demo
Call: +248 4 671 903 Mail: [email protected]
Log In Open Account
Log In Open Account
Log In Open Account
News & Analysis
Open Account
News & Analysis
Open Account

AbbVie posts mixed results for Q1

2 May 2022 By Klavs Valters

Share

AbbVie Inc. reported its financial results for the first quarter before the market open on Friday in the US.

The biotechnology and pharmaceutical company reported revenue just shy of expectations at $13.538 billion (a 4.1% increase year-over-year) in Q1 vs. $13.662 billion expected.

Earnings per share reported at $3.16 per share (a 9.3% increase year-over-year) vs. $3.14 per share expected.

“This year is off to a strong start. Our first quarter results highlight the diversity of our portfolio and include compelling performance from key growth drivers Skyrizi, Rinvoq, Aesthetics and Neuroscience,” Richard A. Gonzalez, Chairman and CEO of the company said in a press release following the first quarter results.

“Our momentum combined with ramping contributions from new products and new indications will drive accelerating revenue and EPS growth through the rest of the year,” he added.

AbbVie Inc. chart

Shares of AbbVie fell by 6.03% on Friday, trading at $144.96 a share.

Here is how the stock has performed in the past year:

  • 1 Month -9.71%
  • 3 Month +50%
  • Year-to-date +48%
  • 1 Year +73%

AbbVie Inc. price targets

  • Morgan Stanley: $192
  • Wells Fargo: $165
  • Goldman Sachs: $140
  • Barclays: $174
  • UBS: $147

AbbVie Inc. is the 33rd largest company in the world with a market cap of $259.43 billion.

You can trade AbbVie Inc. (ABBV) and many other stocks from the NYSE, NASDAQ, HKEX and the ASX with GO Markets as a Share CFD.

Sources: AbbVie Inc., TradingView, CompaniesMarketCap

The information provided is of general nature only and does not take into account your personal objectives, financial situations or needs. Before acting on any information provided, you should consider whether the information is suitable for you and your personal circumstances and if necessary, seek appropriate professional advice. All opinions, conclusions, forecasts or recommendations are reasonably held at the time of compilation but are subject to change without notice. Past performance is not an indication of future performance. Go Markets Pty Ltd, ABN 85 081 864 039, AFSL 254963 is a CFD issuer, and trading carries significant risks and is not suitable for everyone. You do not own or have any interest in the rights to the underlying assets. You should consider the appropriateness by reviewing our TMD, FSG, PDS and other CFD legal documents to ensure you understand the risks before you invest in CFDs. These documents are available here.

#Economy #Economics #Finance #Markets